This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Apr;57(4):571-3; discussion 574.

doi: 10.1016/j.eururo.2009.12.026. Epub 2009 Dec 29.

Prediction models in urology: are they any good, and how would we know anyway?

PMID: 20071072
PMCID: PMC2891896
DOI: 10.1016/j.eururo.2009.12.026

Editorial

Prediction models in urology: are they any good, and how would we know anyway?

Andrew Vickers. Eur Urol. 2010 Apr.

. 2010 Apr;57(4):571-3; discussion 574.

doi: 10.1016/j.eururo.2009.12.026. Epub 2009 Dec 29.

Author

PMID: 20071072
PMCID: PMC2891896
DOI: 10.1016/j.eururo.2009.12.026

No abstract available

PubMed Disclaimer

Comment on

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
Lughezzani G, Budäus L, Isbarn H, Sun M, Perrotte P, Haese A, Chun FK, Schlomm T, Steuber T, Heinzer H, Huland H, Montorsi F, Graefen M, Karakiewicz PI. Lughezzani G, et al. Eur Urol. 2010 Apr;57(4):562-8. doi: 10.1016/j.eururo.2009.12.003. Epub 2009 Dec 10. Eur Urol. 2010. PMID: 20018437

Similar articles

Comparing prediction tools.
Kattan MW. Kattan MW. Eur Urol. 2010 Apr;57(4):569-70; discussion 574. doi: 10.1016/j.eururo.2010.01.006. Epub 2010 Jan 14. Eur Urol. 2010. PMID: 20080334 No abstract available.
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
Lughezzani G, Budäus L, Isbarn H, Sun M, Perrotte P, Haese A, Chun FK, Schlomm T, Steuber T, Heinzer H, Huland H, Montorsi F, Graefen M, Karakiewicz PI. Lughezzani G, et al. Eur Urol. 2010 Apr;57(4):562-8. doi: 10.1016/j.eururo.2009.12.003. Epub 2009 Dec 10. Eur Urol. 2010. PMID: 20018437
Editorial comment on: prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
Ciatto S. Ciatto S. Eur Urol. 2010 Apr;57(4):630. doi: 10.1016/j.eururo.2009.03.079. Epub 2009 Apr 3. Eur Urol. 2010. PMID: 19375847 No abstract available.
[Indications for and results of radical prostatectomy].
Graefen M, Hammerer PG, Haese A, Huland H. Graefen M, et al. Urologe A. 2003 Sep;42(9):1203-11. doi: 10.1007/s00120-003-0429-x. Urologe A. 2003. PMID: 14504753 Review. German.
Failure after radical prostatectomy.
Neulander EZ, Soloway MS. Neulander EZ, et al. Urology. 2003 Jan;61(1):30-6. doi: 10.1016/s0090-4295(02)01918-0. Urology. 2003. PMID: 12559261 Review. No abstract available.

See all similar articles

Cited by

A Nomogram for Predicting the Likelihood of Obstructive Sleep Apnea to Reduce the Unnecessary Polysomnography Examinations.
Luo M, Zheng HY, Zhang Y, Feng Y, Li DQ, Li XL, Han JF, Li TP. Luo M, et al. Chin Med J (Engl). 2015 Aug 20;128(16):2134-40. doi: 10.4103/0366-6999.162514. Chin Med J (Engl). 2015. PMID: 26265604 Free PMC article.
Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.
Seo WI, Kang PM, Kang DI, Yoon JH, Kim W, Chung JI. Seo WI, et al. J Korean Med Sci. 2014 Sep;29(9):1212-6. doi: 10.3346/jkms.2014.29.9.1212. Epub 2014 Sep 2. J Korean Med Sci. 2014. PMID: 25246738 Free PMC article.
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer.
Haddad BR, Erickson A, Udhane V, LaViolette PS, Rone JD, Kallajoki MA, See WA, Rannikko A, Mirtti T, Nevalainen MT. Haddad BR, et al. Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1642-1651. doi: 10.1158/1055-9965.EPI-18-1358. Epub 2019 Jul 10. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31292140 Free PMC article.
Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.
Vedder MM, Márquez M, de Bekker-Grob EW, Calle ML, Dyrskjøt L, Kogevinas M, Segersten U, Malmström PU, Algaba F, Beukers W, Ørntoft TF, Zwarthoff E, Real FX, Malats N, Steyerberg EW. Vedder MM, et al. PLoS One. 2014 Jun 6;9(6):e96849. doi: 10.1371/journal.pone.0096849. eCollection 2014. PLoS One. 2014. PMID: 24905984 Free PMC article.
External Validation of the Cancer of the Prostate Risk Assessment Postsurgical Score for Prediction of Disease Recurrence after Radical Prostatectomy.
Yıkılmaz TN, Öztürk E, Güven EO, Başar H. Yıkılmaz TN, et al. Adv Med. 2016;2016:8639041. doi: 10.1155/2016/8639041. Epub 2016 Oct 19. Adv Med. 2016. PMID: 27833937 Free PMC article.

See all "Cited by" articles

References

1. Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW. An updated catalog of prostate cancer predictive tools. Cancer. 2008;113:3075–99. - PubMed
1. Lughezzani G, Budäus L, Isbarn H, et al. Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy. Eur Urol. In press. - PubMed
1. Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98:715–7. - PMC - PubMed
1. Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005;23:7005–12. - PMC - PubMed
1. Walz J, Chun FK, Klein EA, et al. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol. 2009;181:601–7. discussion 607[en]8. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

P50 CA092629/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information